Wyeth v Levine

Wyeth v Levine

Amicus brief to the U.S. Supreme Court arguing that the U.S. Food and Drug Administration’s (FDA)’s approval of a prescription drug’s label does not preempt failure-to-warn claims under state laws. The brief, which was filed on behalf 10 current and former editors and contributing authors of the New England Journal of Medicine in their first-ever legal brief, argues that the FDA lacks sufficient information and resources to serve as the sole monitor of pharmaceutical risks, that federal preemption of failure-to-warn claims would pose a serious threat to public health and safety, and that effective monitoring of drug risks requires a robust tort system. The brief was authored by Gerson H. Smoger, former President of the Public Justice Foundation, with assistance from Public Justice Senior Attorney Leslie Brueckner. 



C.C.P.A.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.